NVNO vs. EW

In the year-to-date period, NVNO achieves a -9.44% return, which is significantly lower than EW's 2.72% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for enVVeno Medical Corporation (NVNO) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current NVNO Sharpe Ratio is -0.81, which is lower than the EW Sharpe Ratio of -0.32. The chart below compares the historical Sharpe Ratios of NVNO and EW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither NVNO nor EW has paid dividends to shareholders.

The maximum NVNO drawdown since its inception was -98.38%, which is greater than EW's maximum drawdown of -54.32%. Use the drawdown chart below to compare losses from any high point for NVNO and EW. For additional features, visit the drawdowns tool.

enVVeno Medical Corporation (NVNO) has a higher volatility of 21.03% compared to Edwards Lifesciences Corporation (EW) at 11.47%. This indicates that NVNO's price experiences larger fluctuations and is considered to be riskier than EW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between enVVeno Medical Corporation and Edwards Lifesciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.